Kingsley works with Harvard University to develop super-safe cells against natural viruses

To modify the antiviral power of human cell lines, scientists are using a method called DNA recoding to modify about 1 percent of the genome, including the sequence of exons and attachments of all genes, leaving the vast majority of non-coding regions intactKingsley will support research such as DNA Synthesis Services for this collaborationlarge-scale modification of the genome can also help improve cell survival by making cells less susceptible to cancer and better protecting them from extreme conditions such as radiationIn addition, the project will help to develop more economical and accessible next-generation genomics tools and technologies that can be applied more widely to the scientific communityProfessor Church is working with Professor Jeff Boeke of NYU Langone Medical CenterAmong them, the Super Safe Cell Project was built on the successful experience of The Genome Writing Program 2.0 (Sc2.0), led by Professor Jeff BoekeAs part of the genome writing program, a number of academic institutions are working on all aspects of safe cell-related workKingsley has long supported the project and was the only commercial organization involved in the Sc2.0 project in 2011 to create the world's first eukaryotic synthesis genome for high-value industrial applicationsIn May 2018, Kingsley also joined the newly formed Industry Advisory Board of the Genomics Development ProgramNote: Cut in the original text